Literature DB >> 12725892

Short-term cerebral ischemia causes the dysfunction of interneurons and more excitation of pyramidal neurons in rats.

Jin Hui Wang1.   

Abstract

Neural excitotoxicity is a typical factor in the early phase pathogenesis of cerebral ischemia. Its cellular and molecular mechanisms are still unclear and clinical approaches are still lacking of promising therapies. We have examined the vulnerability of cortical neurons to short-term ischemia in rats by simultaneously analyzing the activities of inhibitory and principal neurons in brain slices. Our results demonstrate that short-term in vitro ischemia permanently impairs the excitability of inhibitory neurons (IN) and synaptic transmission mediated by gamma-aminobutyric acid (GABA). However, principal neurons appear to be more exciting during the reperfusion. The vulnerability of inhibitory neurons to ischemia acquires during postnatal development. Our findings signify a major contribution of the ischemic dysfunction of inhibitory neurons to neural excitotoxicity as well as a strategy to prevent the progress of ischemic stroke by protecting inhibitory neurons.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12725892     DOI: 10.1016/s0361-9230(03)00026-1

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  47 in total

Review 1.  GABAergic interneuron origin of schizophrenia pathophysiology.

Authors:  Kazu Nakazawa; Veronika Zsiros; Zhihong Jiang; Kazuhito Nakao; Stefan Kolata; Shuqin Zhang; Juan E Belforte
Journal:  Neuropharmacology       Date:  2011-01-26       Impact factor: 5.250

2.  Frequency-dependent reliability of spike propagation is function of axonal voltage-gated sodium channels in cerebellar Purkinje cells.

Authors:  Zhilai Yang; Jin-Hui Wang
Journal:  Cerebellum       Date:  2013-12       Impact factor: 3.847

3.  Oxygen-Glucose Deprivation Differentially Affects Neocortical Pyramidal Neurons and Parvalbumin-Positive Interneurons.

Authors:  Nadya Povysheva; Aparna Nigam; Alyssa K Brisbin; Jon W Johnson; Germán Barrionuevo
Journal:  Neuroscience       Date:  2019-05-30       Impact factor: 3.590

4.  Androgens predispose males to GABAA-mediated excitotoxicity in the developing hippocampus.

Authors:  Joseph L Nuñez; Margaret M McCarthy
Journal:  Exp Neurol       Date:  2008-01-19       Impact factor: 5.330

5.  Upregulation of barrel GABAergic neurons is associated with cross-modal plasticity in olfactory deficit.

Authors:  Hong Ni; Li Huang; Na Chen; Fengyu Zhang; Dongbo Liu; Ming Ge; Sudong Guan; Yan Zhu; Jin-Hui Wang
Journal:  PLoS One       Date:  2010-10-29       Impact factor: 3.240

6.  Neuronal HIF-1 alpha protein and VEGFR-2 immunoreactivity in functionally related motor areas following a focal M1 infarct.

Authors:  Ann M Stowe; Erik J Plautz; Phuong Nguyen; Shawn B Frost; Ines Eisner-Janowicz; Scott Barbay; Numa Dancause; Anirban Sensarma; Michael D Taylor; Elena V Zoubina; Randolph J Nudo
Journal:  J Cereb Blood Flow Metab       Date:  2007-09-26       Impact factor: 6.200

7.  Imaging rapid redistribution of sensory-evoked depolarization through existing cortical pathways after targeted stroke in mice.

Authors:  Albrecht Sigler; Majid H Mohajerani; Timothy H Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-01       Impact factor: 11.205

8.  TREK-1, a K+ channel involved in neuroprotection and general anesthesia.

Authors:  C Heurteaux; N Guy; C Laigle; N Blondeau; F Duprat; M Mazzuca; L Lang-Lazdunski; C Widmann; M Zanzouri; G Romey; M Lazdunski
Journal:  EMBO J       Date:  2004-06-03       Impact factor: 11.598

9.  Sustained focal cortical compression reduces electrically-induced seizure threshold.

Authors:  M C Ding; E H Lo; G B Stanley
Journal:  Neuroscience       Date:  2008-04-22       Impact factor: 3.590

10.  A sequential impairment of cortical astrocytes and GABAergic neurons during ischemia is improved by mGluR₁,₅ activation.

Authors:  Zhan Liu; Wei Huo; Wei Sun; Manhua Lv; Fang Li; Zhiqiang Su
Journal:  Neurol Sci       Date:  2012-10-31       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.